Financial Daily from THE HINDU group of publications
Thursday, Jul 04, 2002
Financial Daily from THE HINDU group of publications Thursday, Jul 04, 2002 |
|
|
|
|
|
Corporate
-
Outlook Sanofi-Synthelabo eyes 20% growth in topline Our Bureau
MUMBAI, July 3 SANOFI-SYNTHELABO (India) Ltd expects to witness 18-20 per cent growth in topline for the financial year 2002-03. Speaking to newspersons here on the occasion of the parent company Sanofi-Synthelabo group listing on the New York Stock Exchange, Dr Shailesh Ayyangar, Managing Director, Sanofi-Synthelabo India Ltd, said that the company expected a turnover of Rs 60 crore, a 18-20 per cent growth over last year's sales. On the group's plans for its wholly-owned Indian subsidiary, Dr Ayyangar said: "During the course of next few years, Sanofi-Synthelabo India will be actively pursuing the path of augmenting and diversifying its product portfolio through launching of new products.'' Sanofi-Synthelabo (India) Ltd would be launching 8-10 products in the next two to three years in India. "We would be introducing these products in a phased manner. This would be achieved through a careful selection of products to be launched from the strong stable of products from our parent company, new molecules being considered for registration in India from the company's research and development pipeline and through targeted acquisitions,'' Dr Ayyangar said. The company has a presence in segments such as central nervous system, cardiology, epilepsy and thrombosis. According to Dr Ayyangar, the company plans to enter many more segments, particularly neuropsychiatry, in the ensuing years in the Indian pharmaceutical market. The company will introduce one product by the end of 2002 or early 2003, Dr Ayyangar said. The company has about 175 medical representatives and plans to expand the field force when required, he added. On being queried about alliances with Indian companies, Dr Ayyangar said that the company is open to alliances with Indian companies. "We have been approached by several blue-chip Indian companies for alliances,'' he said.
Send this article to Friends by E-Mail
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | The Sportstar | Frontline | Home |
Copyright © 2002, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|